Balance and gait in progressive supranuclear palsy: a narrative review of objective metrics and exercise interventions
- PMID: 37426438
- PMCID: PMC10327556
- DOI: 10.3389/fneur.2023.1212185
Balance and gait in progressive supranuclear palsy: a narrative review of objective metrics and exercise interventions
Abstract
Background: The use of objective gait and balance metrics is rapidly expanding for evaluation of atypical parkinsonism, and these measures add to clinical observations. Evidence for rehabilitation interventions to improve objective measures of balance and gait in atypical parkinsonism is needed.
Aim: Our aim is to review, with a narrative approach, current evidence on objective metrics for gait and balance and exercise interventions in progressive supranuclear palsy (PSP).
Methods: Literature searches were conducted in four computerized databases from the earliest record up to April 2023: PubMed, ISI's Web of Knowledge, Cochrane's Library, and Embase. Data were extracted for study type (cross-sectional, longitudinal, and rehabilitation interventions), study design (e.g., experimental design and case series), sample characteristics, and gait and balance measurements.
Results: Eighteen gait and balance (16 cross-sectional and 4 longitudinal) and 14 rehabilitation intervention studies were included. Cross-sectional studies showed that people with PSP have impairments in gait initiation and steady-state gait using wearable sensors, and in static and dynamic balance assessed by posturography when compared to Parkinson's disease (PD) and healthy controls. Two longitudinal studies observed that wearable sensors can serve as objective measures of PSP progression, using relevant variables of change in turn velocity, stride length variability, toe off angle, cadence, and cycle duration. Rehabilitation studies investigated the effect of different interventions (e.g., balance training, body-weight supported treadmill gait, sensorimotor training, and cerebellar transcranial magnetic stimulation) on gait, clinical balance, and static and dynamic balance assessed by posturography measurements. No rehabilitation study in PSP used wearable sensors to evaluate gait and balance impairments. Although clinical balance was assessed in 6 rehabilitation studies, 3 of these studies used a quasi-experimental design, 2 used a case series, only 1 study used an experimental design, and sample sizes were relatively small.
Conclusion: Wearable sensors to quantify balance and gait impairments are emerging as a means of documenting progression of PSP. Robust evidence for improving balance and gait in PSP was not found for rehabilitation studies. Future powered, prospective and robust clinical trials are needed to investigate the effects of rehabilitation interventions on objective gait and balance outcomes in people with PSP.
Keywords: balance; gait; objective measurements; progressive supranuclear palsy; rehabilitation.
Copyright © 2023 Dale, Silva-Batista, de Almeida and Horak.
Conflict of interest statement
FH is a part-time employee of Clario, that makes APDM Opals for clinical trials. This potential conflict has been managed by Oregon Health and Science University. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.JBI Database System Rev Implement Rep. 2016 Jun;14(6):148-95. doi: 10.11124/JBISRIR-2016-2002352. JBI Database System Rev Implement Rep. 2016. PMID: 27532657 Review.
-
The Role of Rehabilitation in Patients With Progressive Supranuclear Palsy: A Narrative Review.PM R. 2018 Jun;10(6):636-645. doi: 10.1016/j.pmrj.2017.12.011. Epub 2018 Jan 31. PM R. 2018. PMID: 29366918 Review.
-
Remote at-home wearable-based gait assessments in Progressive Supranuclear Palsy compared to Parkinson's Disease.BMC Neurol. 2023 Dec 11;23(1):434. doi: 10.1186/s12883-023-03466-2. BMC Neurol. 2023. PMID: 38082255 Free PMC article.
-
Perspective: Balance Assessments in Progressive Supranuclear Palsy: Lessons Learned.Front Neurol. 2022 Jan 27;13:801291. doi: 10.3389/fneur.2022.801291. eCollection 2022. Front Neurol. 2022. PMID: 35153996 Free PMC article.
-
Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy.Parkinsonism Relat Disord. 2023 Apr;109:105345. doi: 10.1016/j.parkreldis.2023.105345. Epub 2023 Feb 24. Parkinsonism Relat Disord. 2023. PMID: 36868037
References
-
- Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogenous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia, and dementia. Arch Neurol. (1964) 10:333–59. doi: 10.1001/archneur.1964.00460160003001, PMID: - DOI - PubMed
-
- Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al. . Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain. (2005) 128:1247–58. doi: 10.1093/brain/awh488, PMID: - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous